EUVIMEDEUVIMED entdecken
Crossref

LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease

Di Wu, Yanling Lin, Wenjun Guo, Zengling Wang, Yan Chang, Jing Yan, Daqing Han, Ke Xiang, Zhen Yang

Experimental Brain Research · 2026

DOI: 10.1007/s00221-026-07364-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Brain Research, 2026. Verfasst von Di Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Metabolomics, Drugs, Chinese Herbal. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Jilin Provincial Health Commission Health and Technology Capacity Improvement Plan Project, Jilin Provincial Administration of Traditional Chinese Medicine Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive impairment of cognition, behavior, and functional abilities that can ultimately lead to death. Cognitive Formula 1 (CF1), a traditional Chinese medicine (TCM) formulation, has demonstrated promising therapeutic efficacy in clinical applications. However, the precise mechanisms underlying its therapeutic effects in AD remain unclear. An AD rat model was established by intracerebral injection of amyloid-β peptide 1-42 (Aβ₁₋₄₂) to investigate the mechanism of CF1. The results indicated that synergistic interactions among multiple CF1 components influence host metabolic pathways, in particular those involved in glycerophospholipid and amino acid metabolism, thereby suggesting an explanation for the alleviation of systemic metabolic dysregulation by the formulation. CF1 also remodeled the gut microbiota by reducing the abundance of potentially detrimental bacteria, such as Veillonella and Lachnoclostridium, while enhancing that of beneficial bacteria, such as Roseburia. These changes improved intestinal homeostasis, reduced endotoxin influx, and alleviated systemic inflammation. The concurrent improvements in host metabolism and gut microbial composition prevented peripheral pro-inflammatory and oxidative stress signals from reaching the brain, thus inhibiting overactivation of hippocampal microglia and attenuating neuroinflammation. These effects preserved neuronal structure and function, ultimately enhancing learning, memory, and spatial cognition in AD model rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesMetabolomicsDrugs, Chinese HerbalAnimalsRatsMaleDisease Models, AnimalRats, Sprague-DawleyPeptide FragmentsGastrointestinal MicrobiomeChromatography, LiquidMass SpectrometryHippocampusBrainOxidative Stress

Stichwörter der Autor:innen

16S rRNAAlzheimer’s diseaseCognitive formula 1Metabolomics

Substanzen

Amyloid beta-PeptidesPeptide FragmentsDrugs, Chinese Herbalamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China.
  • Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China. xiangke1961@163.com.
  • Jilin Academy of Chinese Medical Sciences, Changchun, 130012, Jilin, China. yangzhen9099@163.com.

Förderung

  • Jilin Provincial Health Commission Health and Technology Capacity Improvement Plan Project
  • Jilin Provincial Administration of Traditional Chinese Medicine Science and Technology Project

Zitieren

APA

Wu, D., Lin, Y., Guo, W., Wang, Z., Chang, Y., Yan, J., Han, D., Xiang, K., & Yang, Z. (2026). LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease. Experimental Brain Research. https://doi.org/10.1007/s00221-026-07364-0

Vancouver

Wu D, Lin Y, Guo W, Wang Z, Chang Y, Yan J, et al. LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease. Experimental Brain Research. 2026. doi:10.1007/s00221-026-07364-0

BibTeX
@article{Wu2026,
  author = {Wu, Di and Lin, Yanling and Guo, Wenjun and Wang, Zengling and Chang, Yan and Yan, Jing and Han, Daqing and Xiang, Ke and Yang, Zhen},
  title = {LC-MS-based metabolomics reveals the In Vivo effects of cognitive formula 1 in rats with Aβ-induced Alzheimer’s disease},
  journal = {Experimental Brain Research},
  year = {2026},
  doi = {10.1007/s00221-026-07364-0}
}
Kostenlos starten →